Singapore's BIOBOT Surgical raises $15.4 million to expand US operations, advance robotic prostate cancer diagnosis, and strengthen global healthcare growth.
Journals
Editor's Guest
Ensuring Excellent Mobile Connectivity for...
Technology in Cancer Care: A story of evolving...
Bringing Shop Floor to Manufacturer's palm:...
Singapore startup K25 AI secures $2M from a Nasdaq-listed firm to expand enterprise AI solutions, boost growth, and strengthen…
Singapore’s Sharpa powers the H2 humanoid robot with advanced robotic hand technology, strengthening its role in the global AI…
Singtel reports higher annual profit, expands AI-ready data centers with Nvidia, and warns of inflation risks from the Iran…
Asia’s startup ecosystem sees strong funding, M&A, and IPO activity across AI, EVs, cybersecurity, quick commerce, and digital…
Indian fintech Progcap plans to raise $45 million to expand MSME lending, strengthen its technology platform, and improve access…
Singapore-based DayOne is considering a dual IPO in Singapore and the US as it expands AI-focused data center infrastructure…
